Gold Falls Over 1%; Uber Shares Decline After Q3 Results

U.S. equities experienced a broad downturn on Tuesday, with the Nasdaq Composite falling over 1.6% alongside the Dow and S&P 500. Notably, Uber Technologies shares declined over 6% despite exceeding Q3 2025 revenue and EPS estimates, while Norwegian Cruise Line, JELD-WEN, and Sarepta Therapeutics also saw significant drops following missed earnings, reduced guidance, and clinical trial setbacks, respectively. This negative sentiment extended to most European and Asian markets, with commodities also trading lower.

Analysis

U.S. equities experienced a broad downturn on Tuesday, with the Nasdaq Composite falling 1.65%, the S&P 500 declining 1.05%, and the Dow dropping 0.60%. Information technology stocks led the decline with a 1.8% fall, contrasting with financial shares which gained 0.4%.

Despite reporting a 20% year-over-year revenue growth to $13.47 billion and adjusted EPS of $0.81, both exceeding consensus estimates, Uber Technologies (UBER) shares declined over 6%. This suggests investor focus on other aspects or forward guidance not detailed. Conversely, Norwegian Cruise Line (NCLH) dropped 15% due to a Q3 revenue miss, and JELD-WEN (JELD) plummeted 28% after missing Q3 estimates and cutting FY25 guidance. Sarepta Therapeutics (SRPT) fell 31% following disappointing Q3 results and its ESSENCE study failing its primary endpoint.

Amidst the broader market decline, several companies experienced substantial gains driven by specific catalysts. Evoke Pharma (EVOK) surged 133% on news of its definitive acquisition agreement, while Denny’s Corporation (DENN) rose 50% following an all-cash acquisition deal valued at approximately $620 million. PTL Limited (PTLE) also saw a 49% boost after reporting a year-over-year increase in H1 EPS results.

The negative sentiment extended globally, with most European and Asian markets closing lower, and commodities such as oil, gold, silver, and copper all trading down. The Logistics Manager's Index remained unchanged at 57.4 in October, providing a stable but non-accelerating economic backdrop to the day's market movements.

Key Decisions for Investors

• Investors should consider re-evaluating their exposure to the information technology sector given its significant underperformance and the broader negative market sentiment.
• Focus on the quality of earnings and forward guidance, as Uber's decline despite beats indicates that headline figures alone may not drive positive stock performance.
• Monitor for M&A catalysts, as demonstrated by Evoke Pharma and Denny's, which can provide substantial upside even in a down market.
• Exercise caution with companies facing critical clinical trial readouts or those issuing downward revisions to financial guidance, as these events can trigger significant stock depreciation.